0001607062-21-000244.txt : 20210802
0001607062-21-000244.hdr.sgml : 20210802
20210802080409
ACCESSION NUMBER: 0001607062-21-000244
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210729
FILED AS OF DATE: 20210802
DATE AS OF CHANGE: 20210802
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: PETKANAS DEAN
CENTRAL INDEX KEY: 0000944235
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-55657
FILM NUMBER: 211134801
MAIL ADDRESS:
STREET 1: 3805 OLD EASTON ROAD
CITY: DOYLESTOWN
STATE: PA
ZIP: 18902
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NEUROPATHIX, INC.
CENTRAL INDEX KEY: 0001615999
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 462645343
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3805 OLD EASTON ROAD
CITY: DOYLESTOWN
STATE: PA
ZIP: 18902
BUSINESS PHONE: 858-883-2642
MAIL ADDRESS:
STREET 1: 3805 OLD EASTON ROAD
CITY: DOYLESTOWN
STATE: PA
ZIP: 18902
FORMER COMPANY:
FORMER CONFORMED NAME: Neuropathix, Inc.
DATE OF NAME CHANGE: 20201112
FORMER COMPANY:
FORMER CONFORMED NAME: Kannalife Inc
DATE OF NAME CHANGE: 20181113
FORMER COMPANY:
FORMER CONFORMED NAME: TYG Solutions Corp.
DATE OF NAME CHANGE: 20140821
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0306
4
2021-07-29
0
0001615999
NEUROPATHIX, INC.
NPTX
0000944235
PETKANAS DEAN
3805 OLD EASTON ROAD
DOYLESTOWN
PA
18902
1
1
1
0
Chief Executive Officer
Common Stock
2021-07-29
4
A
0
1875000
0.048
A
24859029
I
See Note
The reporting person agreed to accept 1,875,000 restricted shares of the issuers common stock in exchange for the discharge of an aggregate of $90,000 of accrued but unpaid monies payable by the issuer to the reporting person as a portion of his salary. The issuance was completed on July 29, 2021. The price of the shares acquired by the reporting person is equal to the closing price of the Company's common stock on July 28, 2021, which was $0.048 per share.
Aggregate amount of shares beneficially owned by the reporting person includes shares held by him directly as well as indirectly through Powerlife Phytomedical, LLC and Golden Gate Capital Partners, LLC. The reporting person disclaims beneficial ownership of the securities held by Powerlife Phytomedical, LLC and Golden Gate Capital Partners, LLC, except to the extent of his pecuniary interest therein.
/s/ Dean Petkanas
2021-08-02